AlphaCentric Advisors LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.

Quarter-by-quarter ownership
AlphaCentric Advisors LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2021$382,000
-49.2%
20,000
-34.4%
0.11%
-41.9%
Q3 2021$752,000
-13.8%
30,500
-9.0%
0.19%
-19.4%
Q2 2021$872,000
+817.9%
33,500
+1016.7%
0.24%
+640.6%
Q1 2021$95,000
+2.2%
3,000
+50.0%
0.03%
-17.9%
Q4 2020$93,000
+144.7%
2,000
+73.9%
0.04%
+116.7%
Q3 2020$38,000
+18.8%
1,1500.0%0.02%0.0%
Q2 2020$32,0001,1500.02%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 565,890$26,257,0009.39%
Consonance Capital Management LP 1,710,803$79,381,0007.41%
GREAT POINT PARTNERS LLC 917,427$42,569,0006.91%
Avoro Capital Advisors LLC 7,500,000$348,000,0005.99%
Ghost Tree Capital, LLC 500,000$23,200,0005.17%
FRAZIER MANAGEMENT LLC 1,312,999$60,923,0004.69%
Perceptive Advisors 9,166,304$425,316,0004.56%
Ally Bridge Group (NY) LLC 360,000$16,704,0002.86%
Orbimed Advisors 6,645,100$308,333,0002.70%
ACUTA CAPITAL PARTNERS, LLC 164,800$7,647,0002.08%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders